Here are three devicemaker acquisitions posed to benefit heart patients.
- Irvine, Calif.-based Edwards Lifesciences Corp. announced plans in November to purchase Israel-based Valtech Cardio for $690 million. Through the deal, Edwards Lifesciences will expand its services in heart valve repair and replacement.
2. Minneapolis-based Medtronic acquired HeartWare International for about $1.1 billion in August. Framingham, Mass.-based HeartWare produces miniature implantable heart pumps for patients suffering from advanced heart failure.
3. In December, Wayne, Penn.-based Teleflex purchased Vascular Solutions for about $1 billion. Minneapolis-based Vascular Solutions creates catheters designed to improve vascular procedures.
More articles on supply chain:
AbbVie CEO pledges to rein in price hikes
National Cancer Institute unveils ambitious program to hasten drug research
Op-ed: The 1 way pharma can get on Trump’s good side
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
